Sandra Mercado, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8638 |
Mrs. Aurelia E Lopez Ii, L.V.N. Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 82297 Miles Ave, Indio, CA 92201 Phone: 760-342-2422 |
Yessica Arizaga Ramirez, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8600 |
Julie Ann Eidson, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 44374 Palm St, Indio, CA 92201 Phone: 760-342-6616 |
Ms. Martha Elizabeth Gomez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-863-8455 Fax: 760-863-8587 |
Mrs. Gladys Flores, L.V.N. Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8600 |
Heidi Christine Flores, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 44359 Palm St, Indio, CA 92201 Phone: 760-342-6616 |
Melissa Araujo, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8600 |
Alejandro Pinedo, LICENSE VOCATIONAL N Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-863-8455 Fax: 760-863-8587 |
Deborah Ann Moran-villarreal, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 44359 Palm St, Indio, CA 92201 Phone: 760-342-6616 Fax: 760-342-8276 |
Freeman Mambo, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8600 |
Leslie Johnson, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-989-4900 |
Agustina Morales, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47825 Oasis St, Indio, CA 92201 Phone: 760-862-8455 |
Martha Yadira Mendoza, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-459-9756 |
Miss Monica Tellez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8650 |
Kayla Marie Berry, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: Telecare Riverside County Psychiatric Health Facility, Indio, CA 92201 Phone: 760-863-8650 |
Mrs. Amanda Yin, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 81820 Shadow Palm Ave Apt 67, Indio, CA 92201 Phone: 442-615-0284 |
Imogene Hernandez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 44374 Palm St, Indio, CA 92201 Phone: 760-342-6616 |
Ms. Lucy Gonzales Gomez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8600 Fax: 760-863-8603 |
Cassidy Sherry Benner, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 47915 Oasis St, Indio, CA 92201 Phone: 760-863-8650 |
News Archive
Private sector health care employment in the United States reached an all-time high of 10.7 percent of total employment, according to a report released by Altarum Institute's Center for Studying Health Spending.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
A new qualitative study by researchers at Columbia University Mailman School of Public Health found that the majority of women living with HIV would endorse a monthly long acting injectable (LAI) antiretroviral therapy over current daily pills.
Now, a team of scientists at the Reykjavik-based deCODe Genetics, a subsidiary of the U.S. biotech company Amgen, and several universities and hospitals in Iceland, says that the antibodies developed to fight SARS-CoV-2 last for at least four months and do not fade quickly as previously thought.
New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.
› Verified 1 days ago